| Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism E Amabebe, FO Robert, T Agbalalah, ESF Orubu British Journal of Nutrition 123 (10), 1127-1137, 2020 | 273 | 2020 |
| Access to medicines through health systems in low-and middle-income countries S Ozawa, R Shankar, C Leopold, S Orubu Health Policy and Planning 34 (Supplement_3), iii1-iii3, 2019 | 93 | 2019 |
| Veterinary antimicrobial resistance containment in Bangladesh: Evaluating the national action plan and scoping the evidence on implementation ESF Orubu, MH Zaman, MT Rahman, VJ Wirtz Journal of global antimicrobial resistance 21, 105-115, 2020 | 48 | 2020 |
| Medicines for children: flexible solid oral formulations ESF Orubu, C Tuleu Bulletin of the World Health Organization 95 (3), 238, 2017 | 46 | 2017 |
| Waves of attention: patterns and themes of international antimicrobial resistance reports, 1945–2020 KC Overton K, Fortané N, Broom A, Raymond S, Gradmann C, Orubu ESF, Podolsky ... BMJ Global Health 6 (11), 2021 | 30 | 2021 |
| Drug and therapeutics committees in Nigeria: evaluation of scope and functionality JO Fadare, O Ogunleye, R Obiako, S Orubu, O Enwere, AA Ajemigbitse, ... Expert review of clinical pharmacology 11 (12), 1255-1262, 2018 | 29 | 2018 |
| Tackling the blind spot of poor-quality medicines in universal health coverage ESF Orubu, C Ching, MH Zaman, VJ Wirtz Journal of pharmaceutical policy and practice 13, 1-10, 2020 | 27 | 2020 |
| Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and … K Outterson, ESF Orubu, J Rex, C Årdal, MH Zaman Clinical Infectious Diseases 74 (7), 1183-1190, 2022 | 26 | 2022 |
| The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression–a proof-of-concept study SEF Orubu, NJ Hobson, AW Basit, C Tuleu Journal of Pharmacy and Pharmacology 69 (4), 417-431, 2017 | 22 | 2017 |
| The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists A Ferrario, ESF Orubu, MC Adeyeye, MH Zaman, VJ Wirtz BMJ Global Health 4 (4), e001681, 2019 | 18 | 2019 |
| Mapping the antimicrobial supply chain in Bangladesh: A scoping-review-based ecological assessment approach ESF Orubu, MA Samad, MT Rahman, MH Zaman, VJ Wirtz Global Health: Science and Practice 9 (3), 2021 | 15 | 2021 |
| Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria ESF Orubu, FO Robert, M Samuel, D Megbule Health Policy and Planning 34 (Supplement_3), iii20-iii26, 2019 | 15 | 2019 |
| Assessing antimicrobial resistance, utilization, and stewardship in Yemen: an exploratory mixed-methods study ESF Orubu, N Al-Dheeb, C Ching, SB Jawdeh, J Anderson, R Sheikh, ... The American Journal of Tropical Medicine and Hygiene 105 (5), 1404, 2021 | 12 | 2021 |
| WHO essential medicines for children 2011–2019: age-appropriateness of enteral formulations ESF Orubu, J Duncan, C Tuleu, MA Turner, A Nunn Archives of disease in childhood 107 (4), 317-322, 2022 | 11 | 2022 |
| Higher seasonal temperature enhances the occurrence of methicillin resistance of Staphylococcus aureus in house flies (Musca domestica) under hospital and … MA Sobur, MS Islam, ZF Haque, ESF Orubu, A Toniolo, MA Choudhury, ... Folia Microbiologica, 1-11, 2022 | 11 | 2022 |
| Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future KA Oshikoya, IA Oreagba, B Godman, FS Oguntayo, J Fadare, S Orubu, ... Expert review of clinical pharmacology 9 (11), 1505-1515, 2016 | 11 | 2016 |
| The current states, challenges, ongoing efforts, and future perspectives of pharmaceutical excipients in pediatric patients in each country and region J Saito, A Agrawal, V Patravale, A Pandya, S Orubu, M Zhao, GP Andrews, ... Children 9 (4), 453, 2022 | 9 | 2022 |
| Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of … C Ching, ESF Orubu, I Sutradhar, VJ Wirtz, HW Boucher, MH Zaman JAC-Antimicrobial Resistance 2 (3), dlaa068, 2020 | 9 | 2020 |
| Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature … C Ching, ESF Orubu, VJ Wirtz, MH Zaman BMJ open 9 (10), e030747, 2019 | 9 | 2019 |
| Off-label prescribing for children with chronic diseases in Nigeria; findings and implications KA Oshikoya, IA Oreagba, B Godman, J Fadare, S Orubu, A Massele, ... Expert opinion on drug safety 16 (9), 981-988, 2017 | 9 | 2017 |
